European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life
New results from the EORTC-1607-GITCG/ABC-09 phase II study provide biomarker insights alongside efficacy data for pembrolizumab plus CisGem in advanced biliary tract cancer.
Thanks to everyone involved in this international research effort.
🔗 eortc.org/publications/
#WorldCancerResearchDay celebrates the impact of cancer research and the collaboration behind progress against cancer.
EORTC is proud to host the World Cancer Research Day International Event on 23 September in Brussels and support this global initiative.
eortc.org/event/world-ca…